Castle Biosciences CSTL Stock
Castle Biosciences Price Chart
Castle Biosciences CSTL Financial and Trading Overview
| Castle Biosciences stock price | 20.06 USD |
| Previous Close | 13.67 USD |
| Open | 13.55 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 13.2 - 13.77 USD |
| 52 Week Range | 9.26 - 36.1 USD |
| Volume | 612.12K USD |
| Avg. Volume | 405.57K USD |
| Market Cap | 357.66M USD |
| Beta (5Y Monthly) | 1.008372 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.14 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34.63 USD |
CSTL Valuation Measures
| Enterprise Value | 145.75M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.1614904 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.3495862 |
| Price/Book (mrq) | 0.92842793 |
| Enterprise Value/Revenue | 0.957 |
| Enterprise Value/EBITDA | -1.63 |
Trading Information
Castle Biosciences Stock Price History
| Beta (5Y Monthly) | 1.008372 |
| 52-Week Change | -16.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 36.1 USD |
| 52 Week Low | 9.26 USD |
| 50-Day Moving Average | 21.59 USD |
| 200-Day Moving Average | 23.6 USD |
CSTL Share Statistics
| Avg. Volume (3 month) | 405.57K USD |
| Avg. Daily Volume (10-Days) | 1.73M USD |
| Shares Outstanding | 26.69M |
| Float | 25.57M |
| Short Ratio | 5.08 |
| % Held by Insiders | 4.36% |
| % Held by Institutions | 84.56% |
| Shares Short | 758.57K |
| Short % of Float | 3.40% |
| Short % of Shares Outstanding | 2.83% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -47.11% |
| Operating Margin (ttm) | -66.15% |
| Gross Margin | 76.18% |
| EBITDA Margin | -58.74% |
Management Effectiveness
| Return on Assets (ttm) | -14.44% |
| Return on Equity (ttm) | -18.33% |
Income Statement
| Revenue (ttm) | 152.22M USD |
| Revenue Per Share (ttm) | 5.78 USD |
| Quarterly Revenue Growth (yoy) | 56.59% |
| Gross Profit (ttm) | 105.03M USD |
| EBITDA | -89426000 USD |
| Net Income Avi to Common (ttm) | -71719000 USD |
| Diluted EPS (ttm) | -2.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 232.06M USD |
| Total Cash Per Share (mrq) | 8.69 USD |
| Total Debt (mrq) | 12.94M USD |
| Total Debt/Equity (mrq) | 3.36 USD |
| Current Ratio (mrq) | 8.994 |
| Book Value Per Share (mrq) | 14.433 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -45664000 USD |
| Levered Free Cash Flow (ttm) | -40391000 USD |
Profile of Castle Biosciences
| Country | United States |
| State | TX |
| City | Friendswood |
| Address | 505 South Friendswood Drive |
| ZIP | 77546 |
| Phone | 866 788 9007 |
| Website | https://castlebiosciences.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 542 |
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary 35-GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
Q&A For Castle Biosciences Stock
What is a current CSTL stock price?
Castle Biosciences CSTL stock price today per share is 20.06 USD.
How to purchase Castle Biosciences stock?
You can buy CSTL shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Castle Biosciences?
The stock symbol or ticker of Castle Biosciences is CSTL.
Which industry does the Castle Biosciences company belong to?
The Castle Biosciences industry is Diagnostics & Research.
How many shares does Castle Biosciences have in circulation?
The max supply of Castle Biosciences shares is 27.59M.
What is Castle Biosciences Price to Earnings Ratio (PE Ratio)?
Castle Biosciences PE Ratio is now.
What was Castle Biosciences earnings per share over the trailing 12 months (TTM)?
Castle Biosciences EPS is -2.14 USD over the trailing 12 months.
Which sector does the Castle Biosciences company belong to?
The Castle Biosciences sector is Healthcare.
Castle Biosciences CSTL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}